LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

Search

Cencora Inc

Open

SectorGezondheidszorg

325.36 -2.96

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

316.87

Max

332.55

Belangrijke statistieken

By Trading Economics

Inkomsten

906M

566M

Verkoop

2.2B

86B

K/W

Sectorgemiddelde

41.472

57.833

EPS

4.08

Dividendrendement

0.64

Winstmarge

0.659

Werknemers

47,000

EBITDA

858M

1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+19.76% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.64%

2.47%

Volgende Winsten

6 mei 2026

Volgende dividenddatum

1 jun 2026

Volgende Ex Dividend datum

15 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.4B

67B

Vorige openingsprijs

328.32

Vorige sluitingsprijs

325.36

Nieuwssentiment

By Acuity

50%

50%

156 / 351 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 mrt 2026, 22:42 UTC

Winsten

Prudential PLC 2025 Adjusted Operating Profit Rises

17 mrt 2026, 21:40 UTC

Winsten

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 mrt 2026, 23:56 UTC

Marktinformatie

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 mrt 2026, 23:46 UTC

Marktinformatie

Nikkei May Rise After Recent Selloffs -- Market Talk

17 mrt 2026, 23:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 mrt 2026, 23:42 UTC

Marktinformatie

RBA's Return to Policy Tightening Will Work -- Market Talk

17 mrt 2026, 23:38 UTC

Marktinformatie

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 mrt 2026, 23:24 UTC

Marktinformatie

Global Energy Roundup: Market Talk

17 mrt 2026, 23:24 UTC

Marktinformatie

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 mrt 2026, 22:22 UTC

Marktinformatie

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 mrt 2026, 22:20 UTC

Winsten

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 mrt 2026, 22:20 UTC

Winsten

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 mrt 2026, 22:07 UTC

Winsten

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 mrt 2026, 22:05 UTC

Winsten

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 mrt 2026, 22:04 UTC

Winsten

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 mrt 2026, 22:03 UTC

Winsten

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 mrt 2026, 22:01 UTC

Winsten

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 mrt 2026, 22:01 UTC

Winsten

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 mrt 2026, 22:01 UTC

Winsten

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 mrt 2026, 21:26 UTC

Winsten

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 mrt 2026, 21:09 UTC

Winsten

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 mrt 2026, 21:08 UTC

Winsten

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 mrt 2026, 21:08 UTC

Winsten

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mrt 2026, 21:07 UTC

Winsten

Couche-Tard 3Q EPS 82c >ATD.T

17 mrt 2026, 21:06 UTC

Winsten

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q EPS 82c >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q Net $757.2M >ATD.T

17 mrt 2026, 20:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

19.76% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 414.22 USD  19.76%

Hoogste 440 USD

Laagste 380 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Sentiment

By Acuity

156 / 351 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat